Literature DB >> 23730845

Incidence of diabetes mellitus in a population-based cohort of persons with chronic hepatitis B virus infection.

P R Spradling1, B Simons, M Narayanan, J Xing, C Homan, L Bulkow, H Cagle, C D Schraer, B J McMahon.   

Abstract

To investigate the effect of hepatitis B virus (HBV) infection on the development of diabetes mellitus (DM), we compared DM incidence and characteristics of Alaska Native persons with and without HBV infection. From 1990 to 2010, there were 52 incident DM cases among 1309 persons with infection vs 4557 DM cases among 85 698 persons without infection (log-rank test, P = 0.20). Compared to infected persons without DM, those with DM were significantly older (57.0 vs 47.4 years, P < 0.001) and had higher body mass index (34.5 vs 28.4 kg/m(2) , P < 0.001). Genotype, immune active disease and the presence of cirrhosis were not associated with DM. In this population-based cohort with over 20 years of follow-up, there was no effect of HBV infection on DM development.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23730845      PMCID: PMC6432791          DOI: 10.1111/jvh.12071

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  13 in total

1.  Diabetes and prediabetes in patients with hepatitis B residing in North America.

Authors:  Mandana Khalili; Manuel Lombardero; Raymond T Chung; Norah A Terrault; Marc G Ghany; W Ray Kim; Daryl Lau; Mauricio Lisker-Melman; Arun Sanyal; Anna S Lok
Journal:  Hepatology       Date:  2015-09-29       Impact factor: 17.425

2.  Association between hepatitis B virus infection and diabetes mellitus: A meta-analysis.

Authors:  Cuixia Cai; Jun Zeng; Huihui Wu; Rong Shi; Min Wei; Yuan Gao; Wenli Ma
Journal:  Exp Ther Med       Date:  2015-06-03       Impact factor: 2.447

3.  Molecular evaluation of hepatitis B virus infection and predominant mutations of pre-core, basal core promoter and S regions in an Iranian population with type 2 diabetes mellitus: a case-control study.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Fatemeh Saberi
Journal:  BMC Infect Dis       Date:  2022-06-17       Impact factor: 3.667

Review 4.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

5.  Chronic Liver Disease-Associated Hospitalizations Among Adults with Diabetes, National Inpatient Sample, 2001-2012.

Authors:  Kathy K Byrd; Jason M Mehal; Sarah F Schillie; Robert C Holman; Dana Haberling; Trudy Murphy
Journal:  Public Health Rep       Date:  2015 Nov-Dec       Impact factor: 2.792

6.  RNA-seq based transcriptome analysis of hepatitis E virus (HEV) and hepatitis B virus (HBV) replicon transfected Huh-7 cells.

Authors:  Neetu Jagya; Satya Pavan Kumar Varma; Deepshi Thakral; Prashant Joshi; Hemlata Durgapal; Subrat Kumar Panda
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

7.  Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes.

Authors:  Jun Lu; Xuhong Hou; Hong Tu; Zhenghao Tang; Yongbing Xiang; Yuqian Bao; Jianren Gu; Weiping Jia
Journal:  J Diabetes Investig       Date:  2017-03-13       Impact factor: 4.232

8.  Hepatitis B and C virus infection and diabetes mellitus: A cohort study.

Authors:  Yun Soo Hong; Yoosoo Chang; Seungho Ryu; Miguel Cainzos-Achirica; Min-Jung Kwon; Yiyi Zhang; Yuni Choi; Jiin Ahn; Sanjay Rampal; Di Zhao; Roberto Pastor-Barriuso; Mariana Lazo; Hocheol Shin; Juhee Cho; Eliseo Guallar
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

9.  Association of hepatitis B surface antigen seropositivity and hepatitis B surface antibody seropositivity with diabetes: a cross-sectional study based on two Chinese populations in Guangdong, China.

Authors:  Yuan Liu; Chaoqiang Jiang; Yuantao Hao; Lin Xu; Weisen Zhang; Ya Li Jin; Tong Zhu; Tai Hing Lam
Journal:  BMJ Open       Date:  2020-07-20       Impact factor: 2.692

10.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.